Affiliations 

  • 1 Prof. A. GANENDRAN, MD (Bristol). FRCP (E), FFAACS, FFAAACS. The Department of Anesthesiology. University of Malaya, Kuala Lumpur, Malaysia
  • 2 C.W. OGLE. MBBS (Malaya), PhD (West Aust). The Department of Pharmacology. University of Hong Kong, Hong Kong.
Singapore Med J, 1975 Dec;16(4):256-8.
PMID: 1224217

Abstract

Surveys in a number of European and American populations have found the frequency of occurrence of the heterozygotes for the gene for the dibucaine-resistant variant of cholinesterase (E.C.3.1.1.8) to be relatively constant. Similar surveys in Oriental population have shown low incidence of the same gene. This study done on the multi-racial population consisting of 3 major groups shows an absence of the gene for the dibucaine resistant variant of cholinesterase. This is supported by the clinical experience in the use of suxamethonium as a single dose in more than 25,000 individuals.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.